Cell and gene therapy clinical trial services market trends influencing growth
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
From Its 2026 Market Size, What Value Is The Cell And Gene Therapy Clinical Trial Services Market Projected To Reach By 2030?
The size of the cell and gene therapy clinical trial services market has experienced rapid expansion in recent years. It is expected to grow from $4.18 billion in 2025 to $4.62 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.3%. The market’s growth during the preceding period can be attributed to an increasing number of cell and gene therapy clinical trials, a rise in outsourcing to specialized CROs, the growing complexity of trial designs, an expansion of rare disease research, and enhanced regulatory oversight of advanced therapies.
The cell and gene therapy clinical trial services market size is anticipated to undergo significant growth in the coming years. It is projected to reach $6.44 billion by 2030, progressing at a compound annual growth rate (CAGR) of 8.7%. This expansion within the forecast period can be attributed to several factors, such as the increasing demand for late-stage clinical trial services, the rising adoption of digital trial technologies, the expansion of global patient recruitment initiatives, a growing emphasis on real-world evidence integration, and increasing investments in precision clinical research. Prominent trends expected in the forecast period include the increasing adoption of decentralized clinical trial models, the growing use of digital patient recruitment platforms, the rising integration of advanced data management systems, the expansion of global trial site networks, and an enhanced focus on regulatory compliance and trial accuracy.
Access Your Free Sample Report For In-Depth Market Analysis:
What Major Factors Are Driving The Cell And Gene Therapy Clinical Trial Services Market Forward?
The increasing occurrence of genetic conditions is anticipated to drive expansion in the cell and gene therapy clinical trial services market moving ahead. These diseases stem from alterations in an individual’s DNA or genetic makeup. Several factors contribute to this growing prevalence, such as broader access to genetic testing, the presence of genetic mutations, and a higher rate of consanguineous marriages. By fostering the creation of new treatments, customizing therapies for individuals, speeding up the application of research in clinical settings, and broadening choices for those with genetic disorders, cell and gene therapy clinical trial services tackle the increasing incidence of these conditions. An example illustrates this: in 2023, the National Health Service (a UK government department) reported that sickle cell disorder (SCD) was England’s most common genetic condition, affecting approximately 17,000 individuals (NHSE, 2023). Consequently, the escalating occurrence of genetic diseases is a key factor propelling the expansion of the cell and gene therapy clinical trial services market.
What Are The Different Segment Types In The Cell And Gene Therapy Clinical Trial Services Market Segment Breakdown?
The cell and gene therapy clinical trial services market covered in this report is segmented –
1) By Service: Clinical Trial Design And Planning, Supply And Logistic Services, Regulatory Affairs And Compliance, Data Management And Biostatics, Site Management And Monitoring, Other Services
2) By Therapy Type: Gene Therapy, Cell Therapy, Gene Modified Cell Therapy
3) By Indication: Oncology, Hematology, Metabolic Disorders, Infectious Diseases, Neurology, Cardiovascular Diseases, Musculoskeletal Disorders, Other Indications
4) By End-Use: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes, Other End-Users
Subsegments:
1) By Clinical Trial Design And Planning: Protocol Development, Trial Feasibility Studies, Trial Design Consultation, Patient Recruitment And Enrollment Strategy, Risk-Based Monitoring Plans
2) By Supply And Logistic Services: Clinical Trial Supply Chain Management, Cold Chain Logistics, Packaging And Labeling Services, Transportation And Distribution Of Biological Samples, Customs And Import/Export Services
3) By Regulatory Affairs And Compliance: Regulatory Strategy And Consulting, Regulatory Submission And Documentation, Compliance With GMP (Good Manufacturing Practices), Regulatory Pathway Consultation, Clinical Trial Applications (CTAs)
4) By Data Management And Biostatistics: Clinical Data Management (CDM), Statistical Analysis And Reporting, Clinical Data Monitoring, Data Integration And Validation, Electronic Data Capture (EDC) Solutions
5) By Site Management And Monitoring: Site Selection And Initiation, Clinical Monitoring And Site Visits, Patient Recruitment And Retention, Site Training And Support, Site Performance Monitoring
6) By Other Services: Patient Advocacy And Engagement, Real-World Evidence (RWE) Studies, Post-Trial Services, Medical Writing And Documentation, Clinical Trial Auditing And Inspection
Which Trends Are Impacting The Progress Of The Cell And Gene Therapy Clinical Trial Services Market?
Leading companies within the cell and gene therapy clinical trial services market are dedicating efforts to implementing advanced technology, specifically customer relationship management systems, to boost efficiency and secure a competitive edge. This customer relationship management approach streamlines and coordinates interactions with trial participants, healthcare providers, and other stakeholders throughout the clinical trial process. For example, in April 2023, AmerisourceBergen Corporation, a US-based healthcare company, unveiled the Cell and Gene Therapy (CGT) Integration Hub. This platform aims to enhance connectivity and streamline processes across the cell and gene therapy treatment pathway. Backed by AmerisourceBergen’s customer relationship management (CRM) system, it seeks to simplify the path-to-care process, partly by providing physicians and patient services teams with greater visibility throughout the therapy’s development and delivery. The CGT Integration Hub, which incorporates features such as expedited benefits investigation, real-time status tracking, and proactive alerts, is designed to simplify care coordination, reduce barriers, and improve the overall patient and provider experience when delivering cell and gene therapies.
Who Are The Well-Known Companies In The Cell And Gene Therapy Clinical Trial Services Market?
Major companies operating in the cell and gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, IQVIA, Laboratory Corporation of America Holdings, ICON plc, Syneos Health Inc., Catalent Pharma Solutions Inc., Charles River Laboratories International Inc., Parexel International Corporation, PRA Health Sciences Inc., Covance Inc., Medpace Holdings Inc., BioClinica Inc., Precision Medicine Group LLC, Worldwide Clinical Trials LLC, Clinigen Group plc, Evidera Inc., Advarra LLC, Veristat LLC, Clinipace Inc., Celonic AG, Cromsource Inc., Novotech Pty Ltd., MedSource Holdings Inc., Frontage Laboratories Inc.
Get The Full Cell And Gene Therapy Clinical Trial Services Market Report:
Where Is The Cell And Gene Therapy Clinical Trial Services Market Primarily Concentrated By Region?
North America was the largest region in the cell and gene therapy clinical trial services market in 2025. It is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy clinical trial services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Cell And Gene Therapy Clinical Trial Services Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Cell And Gene Therapy Clinical Trial Services Market 2026, By The Business Research Company
Cell And Gene Therapy Supply Chain Or Logistics Market Report 2026
Cell And Gene Therapy Manufacturing Services Market 2026
Genes Therapy Market Report 2026
https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
